Corporate Member Update- BeiGene now BeOne Medicines

BeiGene Unveils Proposed Name Change to BeOne Medicines, Reaffirming Its Mission to Unite Global Community Against Cancer

New name reflects Company’s bold vision to eradicate cancer by harnessing the transformative power of global collaboration and multisectoral partnerships
Company will change its Nasdaq ticker to ONC

SAN MATEO, Calif. & BASEL, Switzerland--(BUSINESS WIRE)-- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced its intent to change the Company’s name to BeOne Medicines Ltd., confirming its commitment to develop innovative medicines to eliminate cancer by partnering with the global community to serve as many patients as possible.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241114671168/en/